Mesenteric fibromatosis is currently a diagnostic and therapeutic challenge. We report a case of mesenteric fibromatosis in a 29-year-old man with a 2-month history of periumbilical fullness who was discovered to have an abdominal mass with hydronephrosis. To the best of our knowledge, we report the first case of hydronephrosis in a mesenteric fibromatosis with Gardner's syndrome, which was successfully treated with a cyclo-oxygenase 2 inhibitor without surgical removal of the mesenteric fibromatosis. The hydronephrosis and mesenteric fibromatosis improved modestly with long-term celecoxib (200 mg twice daily). Our case also highlights the importance of performing a detailed examination in patients with hydronephrosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.urology.2007.07.025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mesenteric desmoid tumor in its cystic form: Case report of a very rare variant.
Radiol Case Rep
February 2025
Department of Surgery « A », Ibn Sina Hospital, Mohammed V University, Faculty of Medicine and Pharmacy, Rabat, Morocco.
Desmoid tumors, also known as deep fibromatosis or desmoid-type fibromatosis, represent a rare subset of deep fibromatoses. It is a locally aggressive tumor, with no specific symptoms, and no metastatic potential. We report a case of a 38-year-old male patient with an abdominal mass.
View Article and Find Full Text PDFA Case Study of Umbilical Hernia Complicated by the Presence of a Desmoid Tumor.
Cureus
November 2024
Department of General Surgery, Sree Balaji Medical College and Hospital, Chennai, IND.
Desmoid tumors or aggressive fibromatosis are locally aggressive benign tumors. These arise anywhere in the body but are commonly seen in the anterior abdominal wall. The main treatment choices are continuous surveillance, adjuvant chemotherapy, surgery, and postoperative chemotherapy.
View Article and Find Full Text PDFActive surveillance in patients with extra-abdominal desmoid-type fibromatosis: a pooled analysis of three prospective observational studies.
Clin Cancer Res
December 2024
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Purpose: Three prospective observational studies (Italy, the Netherlands, France) on active surveillance (AS) in patients with extra-abdominal desmoid-type fibromatosis (DTF) support AS as a frontline approach. Identifying prognostic factors for the failure of AS will help determine the strategy. The aim of this study was to investigate the prognostic impact of clinical and molecular variables in a larger series.
View Article and Find Full Text PDFEnamel Renal Syndrome: A Case Report.
Cureus
October 2024
Oral and Maxillofacial Pathology, Microbiology and Forensic Odontology, Goa Dental College and Hospital, Panjim, IND.
Article Synopsis
- - Amelogenesis imperfecta is a genetic disorder that affects the enamel of teeth, which can lead to problems in both baby and adult teeth, sometimes linked with other health issues.
- - A rare condition called enamel renal syndrome occurs when amelogenesis imperfecta is found alongside kidney stones, which complicates diagnosis due to unclear criteria.
- - The case of a 12-year-old boy with tooth discoloration and kidney stones highlights the importance of thorough medical evaluations to avoid serious complications from these conditions.
Efficacy of Vinblastine and Methotrexate in a Childhood Patient with Progressive Desmoid Fibromatosis of the Lower Jaw: A Case Report.
Tokai J Exp Clin Med
December 2024
Department of Pediatrics, Tokai University School of Medicine, 143 shimokasuya, Isehara, Kanagawa 259-1193, Japan.
Desmoid fibromatosis (DF) is defined as a borderline tumor of the soft tissues with a low malignant potential. The most common tumor sites are the extremity, trunk, abdominal cavity, and head and neck. Surgical resection has been the standard treatment for DF.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!